Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization.
about
Clinical immunologic approaches for the treatment of Alzheimer's diseaseImmunotherapy as treatment for Alzheimer’s diseaseBeyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold.Filamentous bacteriophage fd as an antigen delivery system in vaccinationMolecular basis for passive immunotherapy of Alzheimer's diseaseNeuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's diseaseStimulation of endogenous neurogenesis by anti-EFRH immunization in a transgenic mouse model of Alzheimer's disease.Expression of a 28-kilodalton glutathione S-transferase antigen of Schistosoma mansoni on the surface of filamentous phages and evaluation of its vaccine potential.Structural changes of region 1-16 of the Alzheimer disease amyloid beta-peptide upon zinc binding and in vitro aging.Diminished amyloid-beta burden in Tg2576 mice following a prophylactic oral immunization with a salmonella-based amyloid-beta derivative vaccine.Architectural insight into inovirus-associated vectors (IAVs) and development of IAV-based vaccines inducing humoral and cellular responses: implications in HIV-1 vaccinesBacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.Oral Immunization of Rabbits with S. enterica Typhimurium Expressing Neisseria gonorrhoeae Filamentous Phage Φ6 Induces Bactericidal Antibodies Against N. gonorrhoeae.Inflammaging as a prodrome to Alzheimer's diseaseAnti-amyloid-beta immunotherapy in Alzheimer's disease: relevance of transgenic mouse studies to clinical trials.Antibody response and plasma Abeta1-40 levels in young Microcebus murinus primates immunized with Abeta1-42 and its derivatives.Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies.Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models.Can Alzheimer disease be prevented by amyloid-beta immunotherapy?Murine models of Alzheimer's disease and their use in developing immunotherapies.Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease.Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward.Preparation of cyclo-phen-type ligands: chelators of metal ions as potential therapeutic agents in the treatment of neurodegenerative diseases.Phage proteins are expressed on the surface of Neisseria gonorrhoeae and are potential vaccine candidates
P2860
Q22241380-F3F28CC4-67AD-4066-8422-26A557882CB7Q22241491-40A577D8-2A6C-4E93-9EFE-714F881EBC10Q26795483-18E66815-90F1-4F9C-A4BE-577B9A102B1CQ26864071-C0C64374-1E95-4BD2-82D5-DEA69EC8A10AQ27648521-B8CC4B25-6D01-4B96-AE73-1147FB0418E0Q30054419-A6AD2FCE-2AFE-4DC6-8364-68EE8319E276Q30478932-2B952973-0D4A-4830-88E4-0319B1D64FDBQ30782735-E90ED030-F140-449C-9B43-A4FD703A6282Q33227600-C0C953D4-4C8D-4BAD-8429-6E14CCFA94C8Q33742312-E43ABC78-9BA4-48F4-8F3A-532D648F03C7Q34774808-E4B4F0BD-0262-48D8-BBA3-BA771D6CCA35Q35963673-9C509A96-FF66-47D5-BBF3-469000D7C23DQ36650971-944DB3F3-8FDC-4AFF-B44A-760EC6A37062Q37041389-C00B0BA4-56C3-4F42-938B-F86300897B21Q37041524-B846D4E4-06F3-4AF0-91E1-479CFE768EB8Q37267918-F84C7182-90C0-4246-85E9-D56FFC6ACDFDQ37308949-B3DA3D8C-5888-4B56-AF3C-D29704DA0507Q37655247-31F3F43C-EF7C-4824-82D5-43EA6843B9F7Q37688886-B5D88933-97E5-4A08-988A-0273E959AC04Q37752915-5696634D-32F3-4C9F-BCCF-8B9F49455626Q37810956-D2B2A027-CB6B-49C2-B60D-7E8D47086921Q37984574-7E6954C1-36C9-403C-BB4A-4FB91742250BQ38184618-6511494E-D931-45C8-A695-940C3E089599Q53272750-40671869-E85B-431A-B2AB-02165CDF5637Q58715493-D5162D72-33D5-4F99-8E10-AD46E78AE96C
P2860
Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Reduction of beta-amyloid plaq ...... se by EFRH-phage immunization.
@ast
Reduction of beta-amyloid plaq ...... se by EFRH-phage immunization.
@en
type
label
Reduction of beta-amyloid plaq ...... se by EFRH-phage immunization.
@ast
Reduction of beta-amyloid plaq ...... se by EFRH-phage immunization.
@en
prefLabel
Reduction of beta-amyloid plaq ...... se by EFRH-phage immunization.
@ast
Reduction of beta-amyloid plaq ...... se by EFRH-phage immunization.
@en
P1433
P1476
Reduction of beta-amyloid plaq ...... se by EFRH-phage immunization.
@en
P2093
Beka Solomon
Dan Frenkel
P304
P356
10.1016/S0264-410X(02)00609-6
P407
P577
2003-03-01T00:00:00Z